A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease

In this prospective dataset, FC is a useful tool to help identify quiescent Crohn's disease patients at a low risk of relapse over the ensuing 12 months. FC of 240 μg/g was the optimal cutoff in this cohort.